These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 36194956)

  • 1. In vivo therapeutic effects of small molecule-drug conjugates enhanced by Fc grafting.
    Zheng Y; Xu R; Chen S; Tai W
    Biomaterials; 2022 Nov; 290():121820. PubMed ID: 36194956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mono-amino acid linkers enable highly potent small molecule-drug conjugates by conditional release.
    Zheng Y; Xu R; Cheng H; Tai W
    Mol Ther; 2024 Apr; 32(4):1048-1060. PubMed ID: 38369752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bilirubin Nanoparticle-Assisted Delivery of a Small Molecule-Drug Conjugate for Targeted Cancer Therapy.
    Lee S; Lee Y; Kim H; Lee DY; Jon S
    Biomacromolecules; 2018 Jun; 19(6):2270-2277. PubMed ID: 29712433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancing the Pharmacokinetics and Antitumor Activity of an α-Amanitin-Based Small-Molecule Drug Conjugate via Conjugation with an Fc Domain.
    Gallo F; Korsak B; Müller C; Hechler T; Yanakieva D; Avrutina O; Kolmar H; Pahl A
    J Med Chem; 2021 Apr; 64(7):4117-4129. PubMed ID: 33755471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and Evaluation of ePSMA-DM1: A New Theranostic Small-Molecule Drug Conjugate (T-SMDC) for Prostate Cancer.
    Murce E; Spaan E; Beekman S; van den Brink L; Handula M; Stuurman D; de Ridder C; Dalm SU; Seimbille Y
    Pharmaceuticals (Basel); 2023 Jul; 16(8):. PubMed ID: 37630990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydrophilic Small Molecules That Harness Transthyretin To Enhance the Safety and Efficacy of Targeted Chemotherapeutic Agents.
    Pal A; Albusairi W; Liu F; Tuhin MTH; Miller M; Liang D; Joo H; Amin TU; Wilson EA; Faridi JS; Park M; Alhamadsheh MM
    Mol Pharm; 2019 Jul; 16(7):3237-3252. PubMed ID: 31136717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small molecule-drug conjugates: A novel strategy for cancer-targeted treatment.
    Zhuang C; Guan X; Ma H; Cong H; Zhang W; Miao Z
    Eur J Med Chem; 2019 Feb; 163():883-895. PubMed ID: 30580240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism of bioconjugate therapeutics: why, when, and how?
    Liu H; Bolleddula J; Nichols A; Tang L; Zhao Z; Prakash C
    Drug Metab Rev; 2020 Feb; 52(1):66-124. PubMed ID: 32045530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Linker stability influences the anti-tumor activity of acetazolamide-drug conjugates for the therapy of renal cell carcinoma.
    Cazzamalli S; Corso AD; Neri D
    J Control Release; 2017 Jan; 246():39-45. PubMed ID: 27890855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Orthogonal assembly of a designed ankyrin repeat protein-cytotoxin conjugate with a clickable serum albumin module for half-life extension.
    Simon M; Frey R; Zangemeister-Wittke U; Plückthun A
    Bioconjug Chem; 2013 Nov; 24(11):1955-66. PubMed ID: 24168270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and Evaluation of a Non-Peptide Small-Molecule Drug Conjugate Targeting Integrin α
    Paulus J; Sewald N
    Front Chem; 2022; 10():869639. PubMed ID: 35480387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted cancer therapy: conferring specificity to cytotoxic drugs.
    Chari RV
    Acc Chem Res; 2008 Jan; 41(1):98-107. PubMed ID: 17705444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and Evaluation of Small Molecule Drug Conjugates Harnessing Thioester-Linked Maytansinoids.
    Lo CF; Chiu TY; Liu YT; Huang LR; Yeh TK; Huang KH; Liu KL; Hsu CY; Fang MY; Huang YC; Hsu TA; Chen CT; Tsou LK
    Pharmaceutics; 2022 Jun; 14(7):. PubMed ID: 35890212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Theranostic Small-Molecule Prodrug Conjugates for Targeted Delivery and Controlled Release of Toll-like Receptor 7 Agonists.
    Debnath S; Hao G; Guan B; Thapa P; Hao J; Hammers H; Sun X
    Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting Tumor Associated Phosphatidylserine with New Zinc Dipicolylamine-Based Drug Conjugates.
    Liu YW; Shia KS; Wu CH; Liu KL; Yeh YC; Lo CF; Chen CT; Chen YY; Yeh TK; Chen WH; Jan JJ; Huang YC; Huang CL; Fang MY; Gray BD; Pak KY; Hsu TA; Huang KH; Tsou LK
    Bioconjug Chem; 2017 Jul; 28(7):1878-1892. PubMed ID: 28581724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancing the therapeutic range of a targeted small-molecule tubulysin conjugate for folate receptor-based cancer therapy.
    Leamon CP; Reddy JA; Vlahov IR; Dorton R; Bloomfield A; Vetzel M; Klein PJ; Westrick E; Xu LC; Wang Y
    Cancer Chemother Pharmacol; 2017 Jun; 79(6):1151-1160. PubMed ID: 28451831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design of a Small-Molecule Drug Conjugate for Prostate Cancer Targeted Theranostics.
    Kumar A; Mastren T; Wang B; Hsieh JT; Hao G; Sun X
    Bioconjug Chem; 2016 Jul; 27(7):1681-9. PubMed ID: 27248781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic efficacy and safety of a human fusion construct targeting the TWEAK receptor Fn14 and containing a modified granzyme B.
    Alvarez de Cienfuegos A; Cheung LH; Mohamedali KA; Whitsett TG; Winkles JA; Hittelman WN; Rosenblum MG
    J Immunother Cancer; 2020 Sep; 8(2):. PubMed ID: 32958685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Full-length recombinant antibodies from
    Rashid MH
    MAbs; 2022; 14(1):2111748. PubMed ID: 36018829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Site-Specific Antibody-Drug Conjugates in Triple Variable Domain Fab Format.
    Hwang D; Rader C
    Biomolecules; 2020 May; 10(5):. PubMed ID: 32422893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.